BR112023015991A2 - Métodos para detecção de cadeia leve de neurofilamento no plasma e no líquido cerebrospinal - Google Patents

Métodos para detecção de cadeia leve de neurofilamento no plasma e no líquido cerebrospinal

Info

Publication number
BR112023015991A2
BR112023015991A2 BR112023015991A BR112023015991A BR112023015991A2 BR 112023015991 A2 BR112023015991 A2 BR 112023015991A2 BR 112023015991 A BR112023015991 A BR 112023015991A BR 112023015991 A BR112023015991 A BR 112023015991A BR 112023015991 A2 BR112023015991 A2 BR 112023015991A2
Authority
BR
Brazil
Prior art keywords
methods
cerebrospinal fluid
plasma
detection
light chain
Prior art date
Application number
BR112023015991A
Other languages
English (en)
Inventor
David Holtzman
Hong Jiang
Melissa Budelier
Randall Bateman
Original Assignee
Washington University St Louis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington University St Louis filed Critical Washington University St Louis
Publication of BR112023015991A2 publication Critical patent/BR112023015991A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry

Abstract

métodos para detecção de cadeia leve de neurofilamento no plasma e no líquido cerebrospinal. a presente invenção refere-se a métodos para detectar e opcionalmente quantificar nfl presente no líquido cefalorraquidiano e no sangue e o uso dos métodos para detectar e, opcionalmente, medir os níveis de biomarcadores de nfl indicativos de dano neuronal. também descritos são anticorpos anti-nfl.
BR112023015991A 2021-02-10 2022-02-10 Métodos para detecção de cadeia leve de neurofilamento no plasma e no líquido cerebrospinal BR112023015991A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163147833P 2021-02-10 2021-02-10
US202163183417P 2021-05-03 2021-05-03
US202163197826P 2021-06-07 2021-06-07
PCT/US2022/015998 WO2022173965A1 (en) 2021-02-10 2022-02-10 Methods for detecting neurofilament light chain in plasma and cerebrospinal fluid

Publications (1)

Publication Number Publication Date
BR112023015991A2 true BR112023015991A2 (pt) 2024-01-02

Family

ID=82837306

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023015991A BR112023015991A2 (pt) 2021-02-10 2022-02-10 Métodos para detecção de cadeia leve de neurofilamento no plasma e no líquido cerebrospinal

Country Status (11)

Country Link
EP (1) EP4291892A1 (pt)
JP (1) JP2024507755A (pt)
KR (1) KR20230154307A (pt)
AU (1) AU2022220697A1 (pt)
BR (1) BR112023015991A2 (pt)
CA (1) CA3207924A1 (pt)
CL (1) CL2023002353A1 (pt)
CO (1) CO2023011971A2 (pt)
CR (1) CR20230441A (pt)
IL (1) IL305068A (pt)
WO (1) WO2022173965A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117164711B (zh) * 2023-09-28 2024-01-30 北京凯祥弘康生物科技有限公司 一种抗神经纤维丝轻链蛋白的抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090053723A1 (en) * 2007-08-24 2009-02-26 Shangxi Xiao Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS)
US20170315136A9 (en) * 2009-06-19 2017-11-02 Banyan Biomarkers, Inc. Biomarker assay of neurological condition

Also Published As

Publication number Publication date
AU2022220697A1 (en) 2023-09-21
WO2022173965A1 (en) 2022-08-18
JP2024507755A (ja) 2024-02-21
CA3207924A1 (en) 2022-08-18
CO2023011971A2 (es) 2023-09-29
EP4291892A1 (en) 2023-12-20
CL2023002353A1 (es) 2024-03-08
KR20230154307A (ko) 2023-11-07
CR20230441A (es) 2023-11-10
IL305068A (en) 2023-10-01

Similar Documents

Publication Publication Date Title
IL254331B (en) Sub-pixel and sub-resolution location of defects in sample slices
BR112022007593A2 (pt) Compostos indicadores, dispositivos que compreendem compostos indicadores e métodos de fabricação e uso dos mesmos
BR112018072627A2 (pt) realização de medições óticas em uma amostra
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
DK1776587T3 (da) Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf
BR112017017854A2 (pt) método para detecção de anticorpo monoclonal utilizando espectrometria de massa
NZ593514A (en) p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
EA201170361A1 (ru) Ценный документ и способ определения степени загрязнения или изнашивания такого документа
WO2014015194A3 (en) Methods for detecting and measuring aggregation
BR112014028616A8 (pt) método para a detecção de pelo menos um analito em pelo menos uma amostra de um fluido do corpo, dispositivo e sistema de teste
BR112014019564A8 (pt) Método para determinar a permeabilidade ou uma propriedade indicativa da permeabilidade de um reservatório
EA201101563A1 (ru) Безколбовый спектрометр
EA201190026A1 (ru) Ценный документ, способ изготовления контрольного элемента и способ обнаружения загрязнения или истирания документа
DE602006007379D1 (de) Positionserfassungssystem mit selbstüberwachung für konnektivitätsfehler
CO2018004289A2 (es) Inmunoensayo para detectar quininógeno escindido de alto peso molecular
MX2016006514A (es) Metodo para analizar una muestra que comprende por lo menos un primer y un segundo inhibidores de incrustaciones.
BR112023015991A2 (pt) Métodos para detecção de cadeia leve de neurofilamento no plasma e no líquido cerebrospinal
ES2422740T3 (es) Procedimiento y sistema de detección de un tipo seleccionado de moléculas en una muestra
BR112012020396B8 (pt) Processo e dispositivo de correção de uma medição corrente de pressão de um fluxo gasoso, turbomáquina, e, sistema de medição de pressão de um fluxo gasoso
BR112016008956A2 (pt) Detecção de atividade de clivagem de uma enzima
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
BR112018000452A2 (pt) medições de função de barreira
ATE544064T1 (de) Optische messeinheit und verfahren zur durchführung einer reflexionsmessung
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
BR112016021714A2 (pt) imunoensaio e anticorpos para a detecção de cromogranina a